Replies to post #234473 on Biotech Values

[Femto99]

Thank you. The results are just preliminary readout from this trial which they suppose to enroll 1008 participants. However, for some reason, only less than 100 patients were studied so far.
https://clinicaltrials.gov/ct2/show/NCT04366908

[DewDiligence]

OPK—Paper on the trial in question: https://www.sciencedirect.com/science/article/pii/S0960076020302764

[DewDiligence]

OPK starts COVID-19 phase-2 trial of Rayaldee (calcifediol) in 600 patients—see #msg-158040714 for background on why I’m skeptical of the data from a small IST in Spain:

https://www.globenewswire.com/news-release/2020/09/15/2093569/0/en/OPKO-Health-Initiates-Clinical-Trial-of-RAYALDEE-in-COVID-19-Patients.html